Novel therapeutic targets for allergic airway disease in children

Drugs in Context

article

Alessandro Giallongo¹  Giuseppe Fabio Parisi¹  Amelia Licari²  Giulio Pulvirenti¹  Caterina Cuppari³  Carmelo Salpietro³  Gian Luigi Marseglia²  Salvatore Leonardi¹ 

[1] Department of Clinical and Experimental Medicine, University of Catania;Department of Pediatrics, Foundation IRCCS Policlinico San Matteo, University of Pavia;Department of Human Pathology of the Adult and Developmental Age ‘Gaetano Barresi,’ Unit of Pediatric Emergency, University of Messina

关键词: allergic airway disease;    allergic rhinitis;    asthma;    biologics;    children;    chronic rhinosinusitis;    immunotherapy.;   

DOI  :  10.7573/dic.212590

学科分类：社会科学、人文和艺术（综合）

来源: C S F Medical Communications Ltd.

【 摘 要 】

The aim of precision medicine is setting up targeted therapiesfor selected patients that would ideally have high effectivenessand few side effects. This is made possible by targeted therapydrugs that selectively act on a specific pathway. Precisionmedicine is spreading to many medical specialties, and thereis increasing interest in the context of allergic airway diseases,such as allergic rhinitis, chronic rhinosinusitis, and asthma. Thisreview is an update of new targets in the treatment of childhoodallergic upper airway diseases and asthma, including the mostrecent biologic drugs that have already been licensed or are inthe pipeline to be tested with children.

【 授权许可】

CC BY-NC-ND